Standout Papers

Regorafenib monotherapy for previously treated metastatic colorectal c... 2007 2026 2013 2019 2.0k
  1. Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial (2012)
    Axel Grothey, Eric Van Cutsem et al. The Lancet
  2. Phase III Trial of Infusional Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan (FOLFOXIRI) Compared With Infusional Fluorouracil, Leucovorin, and Irinotecan (FOLFIRI) As First-Line Treatment for Metastatic Colorectal Cancer: The Gruppo Oncologico Nord Ovest (2007)
    Alfredo Falcone, Sergio Ricci et al. Journal of Clinical Oncology
  3. FOLFOXIRI plus bevacizumab versus FOLFIRI plus bevacizumab as first-line treatment of patients with metastatic colorectal cancer: updated overall survival and molecular subgroup analyses of the open-label, phase 3 TRIBE study (2015)
    Chiara Cremolini, Fotios Loupakis et al. The Lancet Oncology
  4. Initial Therapy with FOLFOXIRI and Bevacizumab for Metastatic Colorectal Cancer (2014)
    Fotios Loupakis, Chiara Cremolini et al. New England Journal of Medicine
  5. Prognosis of patients with peritoneal metastatic colorectal cancer given systemic therapy: an analysis of individual patient data from prospective randomised trials from the Analysis and Research in Cancers of the Digestive System (ARCAD) database (2016)
    Jan Franko, Qian Shi et al. The Lancet Oncology
  6. Primary Tumor Location as a Prognostic Factor in Metastatic Colorectal Cancer (2015)
    Fotios Loupakis, Dongyun Yang et al. JNCI Journal of the National Cancer Institute
  7. Quantitative evidence for early metastatic seeding in colorectal cancer (2019)
    Zheng Hu, Jie Ding et al. Nature Genetics
  8. Drug-induced interstitial lung disease during cancer therapies: expert opinion on diagnosis and treatment (2022)
    Pierfranco Conté, P.A. Ascierto et al. ESMO Open

Immediate Impact

9 by Nobel laureates 7 from Science/Nature 76 standout
Sub-graph 1 of 20

Citing Papers

Colorectal cancer
2024 Standout
Sotorasib with panitumumab in chemotherapy-refractory KRASG12C-mutated colorectal cancer: a phase 1b trial
2024 Standout
39 intermediate papers

Works of Alfredo Falcone being referenced

FOLFOXIRI plus bevacizumab versus FOLFIRI plus bevacizumab as first-line treatment of patients with metastatic colorectal cancer: updated overall survival and molecular subgroup analyses of the open-label, phase 3 TRIBE study
2015 Standout
Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial
2012 Standout
and 46 more

Author Peers

Author Last Decade Papers Cites
Alfredo Falcone 13249 5629 3795 4580 605 18.4k
Takayuki Yoshino 11568 5388 3052 2702 697 15.3k
Axel Grothey 13763 4716 2440 2588 329 18.0k
Stefano Cascinu 10996 7058 3338 4135 643 17.8k
Timothy Price 10428 4891 2247 2788 464 14.4k
Michael J. Overman 10938 3816 2991 2587 443 15.9k
Steven R. Alberts 12210 5103 2286 2606 308 16.8k
Aimery de Gramont 19720 6646 2362 2586 332 24.4k
Volker Heinemann 14164 6028 4254 3833 654 19.8k
Joon Oh Park 9002 7439 2818 4426 378 15.8k
Marc Ychou 15774 7558 5031 4114 319 21.6k

All Works

Loading papers...

Rankless by CCL
2026